Related Experiment Video
Updated: Aug 16, 2026
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
Published on: December 19, 2019
[Prevention of carcinogenesis in familial tumors]
1Dept. of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Osaka, Japan.
Abstract:
This report reviews the state of the art of cancer prevention of familial colorectal cancer (familial adenomatous polyposis, hereditary non-polyposis colorectal cancer). A large number of clinical trials have been performed using sulindac, a non-steroidal anti-inflammatory drug (NSAID). Sulindac reduces the size and number of large bowel polyps. However, as yet, it cannot be used for this indication in the clinical setting, because of the frequent occurrence of serious gastrointestinal side effects, and there are a number of cases in which aggressive tumors developed despite a reduction in the size of polyps. Studies on COX-2 selective inhibitors, with minimal side effects on the digestive tract, are showing promising results. In addition to NSAIDs, clinical trials have been performed using vitamins and dietary components. These show minimal side effects, but their efficacy is still insufficient for clinical use, and further studies are anticipated.
Insights
Preventing familial colorectal cancer (CRC) is challenging. While non-steroidal anti-inflammatory drugs (NSAIDs) like sulindac show polyp reduction, side effects limit use. Newer COX-2 inhibitors and dietary components are under investigation for safer, effective familial CRC prevention.
Area of Science:
- Oncology
- Gastroenterology
- Pharmacology
Context:
- Familial colorectal cancer (CRC) encompasses hereditary conditions like familial adenomatous polyposis (FAP) and hereditary non-polyposis colorectal cancer (HNPCC).
- Effective cancer prevention strategies for hereditary CRC syndromes are crucial due to increased cancer risk.
- Current prevention research focuses on pharmacological and dietary interventions.
Purpose:
- To review the current state of the art in cancer prevention for familial colorectal cancer.
- To evaluate the efficacy and safety of interventions, including non-steroidal anti-inflammatory drugs (NSAIDs) and dietary components.
- To identify promising future directions in familial CRC prevention.
Summary:
- Sulindac, a non-steroidal anti-inflammatory drug (NSAID), has been extensively studied for familial adenomatous polyposis (FAP) and hereditary non-polyposis colorectal cancer (HNPCC), demonstrating a reduction in polyp size and number.
- Despite efficacy, sulindac's clinical use is restricted by significant gastrointestinal side effects and instances of aggressive tumor development.
- Selective COX-2 inhibitors show promise for reduced gastrointestinal toxicity.
- Vitamins and dietary components have been explored, exhibiting minimal side effects but insufficient efficacy, necessitating further research.
Impact:
- Identifies limitations of current NSAID-based strategies for familial colorectal cancer prevention.
- Highlights the potential of selective COX-2 inhibitors as a safer alternative.
- Underscores the need for continued research into dietary interventions for improved efficacy and safety in hereditary cancer syndromes.
More Related Videos
13:04In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
05:58Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
Published on: August 20, 2018
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Mutagenicity and Carcinogenicity
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...